ici 118233 has been researched along with rolipram in 1 studies
Studies (ici 118233) | Trials (ici 118233) | Recent Studies (post-2010) (ici 118233) | Studies (rolipram) | Trials (rolipram) | Recent Studies (post-2010) (rolipram) |
---|---|---|---|---|---|
5 | 0 | 0 | 1,604 | 17 | 401 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furman, BL; Pyne, NJ; Shafiee-Nick, R | 1 |
1 other study(ies) available for ici 118233 and rolipram
Article | Year |
---|---|
Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Analysis of Variance; Animals; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Guanidines; Insulin; Insulin Secretion; Islets of Langerhans; Isoenzymes; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrazines; Pyridazines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Thiophenes | 1995 |